Nursing Next Exam Prep Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 06-11-2024
- Paid Up Capital ₹ 0.10 M
as on 06-11-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 119.41%
(FY 2023)
- Profit 210.35%
(FY 2023)
- Ebitda 191.67%
(FY 2023)
- Net Worth 108.25%
(FY 2023)
- Total Assets 33.43%
(FY 2023)
About Nursing Next Exam Prep
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bhupesh Arora, Satish Jain, and Varun Jain serve as directors at the Company.
- CIN/LLPIN
U22219DL2020PTC363901
- Company No.
363901
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 May 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
East Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Nursing Next Exam Prep?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varun Jain  | Director | 17-May-2023 | Current |
| Bhupesh Arora | Director | 17-May-2023 | Current |
| Satish Jain | Director | 17-May-2023 | Current |
Financial Performance of Nursing Next Exam Prep.
Nursing Next Exam Prep Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 119.41% increase. The company also saw a substantial improvement in profitability, with a 210.35% increase in profit. The company's net worth Soared by an impressive increase of 108.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nursing Next Exam Prep?
Unlock access to Nursing Next Exam Prep's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Oxford & Ibh Publishing Company Private LimitedActive 38 years 7 monthsSatish Jain and Varun Jain are mutual person
C B S Publishers And Distributors Private LimitedActive 36 years 2 monthsSatish Jain and Varun Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nursing Next Exam Prep?
Nursing Next Exam Prep has a workforce of 66 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nursing Next Exam Prep, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nursing Next Exam Prep's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
